These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8381695)
21. Cytomegalovirus after heart transplantation: definitions for the guidance of antiviral therapy. Iberer F; Tscheliessnigg K; Halwachs G; Auer T; Wasler A; Petutschnigg B; Schreier G; Müller H; Allmayer T; Prenner G Scand J Infect Dis Suppl; 1995; 99():100-3. PubMed ID: 8668929 [TBL] [Abstract][Full Text] [Related]
22. [Foscarnet therapy for ganciclovir-refractory cytomegalovirus hepatitis in a patient who underwent bone marrow transplantation from an unrelated donor]. Fujisaki T; Gondo H; Uchida N; Matsuo I; Takenaka K; Tanimoto K; Otsuka T; Minematsu T; Minamishima Y; Niho Y Rinsho Ketsueki; 1997 Feb; 38(2):142-5. PubMed ID: 9059069 [TBL] [Abstract][Full Text] [Related]
23. Cytomegalovirus infection after bone marrow transplantation in children. Castagnola E; Cappelli B; Erba D; Rabagliati A; Lanino E; Dini G Hum Immunol; 2004 May; 65(5):416-22. PubMed ID: 15172440 [TBL] [Abstract][Full Text] [Related]
24. Cytomegalovirus surveillance and prevention in allogeneic bone marrow transplantation: examination of a preemptive plan of ganciclovir therapy. Mandanas RA; Saez RA; Selby GB; Confer DL Am J Hematol; 1996 Feb; 51(2):104-11. PubMed ID: 8579049 [TBL] [Abstract][Full Text] [Related]
25. The clinical utility of CMV surveillance cultures and antigenemia following bone marrow transplantation. Humar A; O'Rourke K; Lipton J; Messner H; Meharchand J; Mahony J; Walker I; Wasi P; McGeer A; Moussa G; Chua R; Mazzulli T Bone Marrow Transplant; 1999 Jan; 23(1):45-51. PubMed ID: 10037050 [TBL] [Abstract][Full Text] [Related]
26. No prevention of cytomegalovirus infection by anti-cytomegalovirus hyperimmune globulin in seronegative bone marrow transplant recipients. The Nordic BMT Group. Ruutu T; Ljungman P; Brinch L; Lenhoff S; Lönnqvist B; Ringdén O; Ruutu P; Volin L; Albrechtsen D; Sallerfors B; Ebeling F; Myllylä G Bone Marrow Transplant; 1997 Feb; 19(3):233-6. PubMed ID: 9028551 [TBL] [Abstract][Full Text] [Related]
27. CMV monitoring after peripheral blood stem cell and bone marrow transplantation by pp65 antigen and quantitative PCR. Schulenburg A; Watkins-Riedel T; Greinix HT; Rabitsch W; Loidolt H; Keil F; Mitterbauer M; Kalhs P Bone Marrow Transplant; 2001 Oct; 28(8):765-8. PubMed ID: 11781628 [TBL] [Abstract][Full Text] [Related]
28. [Chronic myelocytic leukemia associated with cytomegalovirus induced sialoadenitis after unrelated allogeneic bone marrow transplantation]. Yoshida M; Ueda S; Harano H; Yamazaki E; Kato K; Tanabe J; Okamoto R; Ogawa K; Mohri H; Okubo T; Sasaki S; Matsuzaki M; Nakatani Y; Chiba N Rinsho Ketsueki; 1996 Jan; 37(1):46-52. PubMed ID: 8683867 [TBL] [Abstract][Full Text] [Related]
29. Fatal cytomegalovirus interstitial pneumonia following autologous peripheral blood stem cell transplantation. Fukuoka Bone Marrow Transplantation Group. Nagafuji K; Eto T; Hayashi S; Tokunaga Y; Gondo H; Niho Y Bone Marrow Transplant; 1998 Feb; 21(3):301-3. PubMed ID: 9489656 [TBL] [Abstract][Full Text] [Related]
31. Ganciclovir and the prevention of CMV disease after allogeneic BMT: policy at the Hammersmith Hospital. Ward KN; Roberts IA; van Rhee F Bone Marrow Transplant; 1994 Feb; 13(2):230-1. PubMed ID: 8205098 [No Abstract] [Full Text] [Related]
32. [Prophylaxis and treatment of cytomegalovirus infection in allogeneic bone marrow transplantation]. Guo N; Lu D; Liu D Zhonghua Xue Ye Xue Za Zhi; 1999 Aug; 20(8):402-4. PubMed ID: 11721418 [TBL] [Abstract][Full Text] [Related]
34. Salivary immunoglobulins in recipients of bone marrow grafts. III. A longitudinal follow-up of CMV specific antibodies. Chaushu G; Chaushu S; Slavin S; Or R; Garfunkel AA; Yefenof E Bone Marrow Transplant; 1996 Feb; 17(2):237-41. PubMed ID: 8640173 [TBL] [Abstract][Full Text] [Related]
35. Prophylaxis of CMV infection after BMT. Zaia JA; Schmidt GM Bone Marrow Transplant; 1992; 10 Suppl 1():139-43. PubMed ID: 1325854 [No Abstract] [Full Text] [Related]
36. Surveillance of cytomegalovirus infections in bone marrow transplant in Trieste: seven years' experience. D'Agaro P; Andolina M; Burgnich P; Samar E; Campello C Haematologica; 2000 Nov; 85(11 Suppl):54-7. PubMed ID: 11268325 [TBL] [Abstract][Full Text] [Related]
37. Successful treatment with ganciclovir for cytomegalovirus duodenitis following allogenic bone marrow transplantation. Ahn JH; Lee JH; Lee KH; Kim WK; Lee JS; Bahng H; Jung HY; Kim YS; Kim O; Kim SH Korean J Intern Med; 1999 Jan; 14(1):91-4. PubMed ID: 10063321 [TBL] [Abstract][Full Text] [Related]
38. Granulocyte recovery in pediatric marrow transplant recipients treated with ganciclovir for cytomegalovirus infection. Roberts WD; Weinberg KI; Kohn DB; Sender L; Parkman R; Lenarsky C Am J Pediatr Hematol Oncol; 1993 Aug; 15(3):320-3. PubMed ID: 8392303 [TBL] [Abstract][Full Text] [Related]
39. Risk-adapted pre-emptive therapy for cytomegalovirus disease in patients undergoing allogeneic bone marrow transplantation. Mori T; Okamoto S; Matsuoka S; Yajima T; Wakui M; Watanabe R; Ishida A; Iwao Y; Mukai M; Hibi T; Ikeda Y Bone Marrow Transplant; 2000 Apr; 25(7):765-9. PubMed ID: 10745263 [TBL] [Abstract][Full Text] [Related]